GIGABYTE
26.3.2020 11:02:27 CET | Business Wire | Press release
(GIGABYTE) As the new Coronavirus rages around the world, many countries have announced lockdown of cities or regions. Many enterprises have begun implementing Work-from-Home policies to protect employees from infection. For those who are already working from home, you fed-up with the performance of your old computer? As for those who have not been quarantined, are you well-prepared to work from home? As a leading laptop manufacturer, GIGABYTE now provides selection guides for different consumer groups and offers excellent discounts. With GIGABYTE’s ultra-performance laptops, not only can you work effortlessly from home, but can also enjoy binge-watching and gaming thanks to their excellent display and immersive sound effects.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20200326005025/en/
As the pandemic spreads, how to work efficiently from home as well as pass time has become the focus of many people. "In addition to laptops’ performance and image quality, what concerns people working from home includes network quality, having enough ports to connect to devices such as screens, convenience of use in every corner of the house (such as the sofa or bed), and the long battery life," says Steven Chen, VP of GIGABYTE Mobility Product Business Group.
Wireless signal too weak? Not enough ports?
GIGABYTE’s AERO and AORUS Series have taken all these concerns into account. For the wireless network coverage and communication quality issues caused by the home environment, GIGABYTE combines Killer Wireless xTend technology to turn its laptops into a wireless range extender, which extends both wired and wireless networks. The latter can even be extended to cover 90 square meters, eliminating all household notspots. Besides, both series have up to nine external ports, including audio and video transmission ones for Display, HDMI, and Thunderbolt. Want to connect to a larger screen at home? You don’t have to waste money on a bunch of adapters anymore. GIGABYTE’s laptops also feature 94Wh batteries, the high capacity of which is twice that of other products in the industry, allowing laptops to work for more than 8-9 hours in high-performance mode.
Fight the Coronavirus together! Special offers for Intel Gen9 high-performance models!
Amid the Coronavirus outbreak, GIGABYTE has launched discounts for different consumer groups, directly launching models that have received both domestic and international recognition, including European Hardware Association’s Best Notebook 2019 and Taiwan Excellence Awards. Since all the discounted laptops have Intel's ninth-generation Core i7 processor, NVIDIA RTX / GTX series graphics cards and are equipped with Windows 10, whether you are someone who has to work from home or just looking for fun, you can easily find a laptop with favorable discounts that fits your personal needs!
For creators pursuing 4K UHD of HDR400 on video/audio quality - AERO 15 OLED
The AERO 15 OLED features the AMOLED 4K UHD screen, high color saturation of HDR400 Certified, ultra-high contrast, 3mm narrow border, ultra-rich and colorful image quality, and supports 100% DCI-P3 color gamut, which is far better than ordinary LCD screens’ 40% NTSC color performance. Having acquired the TÜV Rheinland's hardware low blue light certification, the AERO 15 OLED can reduce harmful blue light by more than 10% compared with ordinary screens, and protect eyes from long-hours of creative work and binge-watching. With the only X-Rite Pantone certified screen in the industry, each panel of the AERO series undergoes independent color correction, allowing its screen color to match the accuracy of the Pantone Matching System!
For people focusing on both business and entertainment – AERO 15 Classic
With a sharp and appealing appearance, the business-like AERO 15 Classic features a thickness of 1.8cm and a weight of 2.0 kg, allowing high portability for working outside once the pandemic ends. Moreover, the performance of NVIDIA GTX / RTX or above is also more than enough to play games. The AERO 15 Classic comes in various panel options, such as the 4K UHD or 144Hz/240Hz gaming monitors, allowing you to enjoy a 4K high image quality or a high refresh rate above 144Hz and to play games without stuttering. It also features X-Rite Pantone certified screens with each panel undergoing independent color correction.
For real hardcore gamers – AORUS 15
The AORUS 15 is the most powerful laptop with a thickness below 2.4cm, Intel Core i7 processor, the highest NVIDIA RTX 2060 graphics card, and unique WINDFORCE Infinity cooling technology, even the waste heat generated by the CPU and GPU can be processed independently without compromising performance. Its sharp 240Hz gaming specifications feature a super high refresh rate, allowing 3A game masterpieces to run smoothly without delay or lag.
For people pursuing high storage capacity with 144Hz display - AORUS 5/7
With the super-optimal 144Hz screen rarely seen among gaming laptops of the same level, the AORUS5/7 weighs 2.15KG and has a thickness of only 23mm, allowing gamers to enjoy lightweight and portability. Its hybrid SSD+HDD drive provides both access speed and large capacity, up to 3 storage interfaces. With a capacity of up to 6TB, you can store large amounts of games or videos without the need of external hard drives.
*For more information, please visit GIGABYTE/AORUS website:
Germany (Deutsch) |
|
France (Français) |
|
Spain (Español) |
|
United Kingdom (English) |
|
Netherlands (Dutch) |
*For more photos, please download here: https://drive.google.com/open?id=1OpkPIRJ6Pc1vSTnW7IehumMRE2YcqHax
GIGABYTE also offers quantity discounts to enterprises. In addition to greater discounts, enterprises can enjoy an extended warranty. For more information, please contact: gswe@gigabyte.com
About GIGABYTE
GIGABYTE is an engineer, visionary, and leader in the world of tech that uses its hardware expertise, patented innovations, and industry leadership to create, inspire and advance. Renowned for over 30 years of award-winning excellence, GIGABYTE is a cornerstone in the HPC community, providing businesses with server and data center expertise to accelerate their success. At the forefront of evolving technology, GIGABYTE is devoted to inventing smart solutions that enable digitalization from edge to cloud, and allow customers to capture, analyze, and transform digital information into economic data that can benefit humanity and "Upgrade Your Life". Please visit https://www.gigabyte.com/ for more information.
View source version on businesswire.com: https://www.businesswire.com/news/home/20200326005025/en/
Link:
Social Media:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Phase 3 RAINIER Results Supporting Best-in-Class Potential of Povetacicept in IgA Nephropathy Published in the New England Journal of Medicine and Presented at the American Society of Nephrology Kidney Week 202623.10.2026 19:42:00 CEST | Press release
- Vertex is on track for the U.S. FDA Prescription Drug User Fee Act (PDUFA) date of November 30 for potential accelerated approval of povetacicept –- Data published in NEJM and presented at ASN highlight povetacicept’s unique trifecta of efficacy, favorable safety, and the simplicity of dosing at-home every 4 weeks with a low-volume autoinjector –- Data presented at ASN include a qualitative study examining patient perspectives on current and emerging IgAN therapies, showing that 96% of participants preferred an autoinjector over a prefilled syringe, and 80% of participants preferred dosing every 4 weeks versus weekly dosing - - New clinical studies of povetacicept underway including a study evaluating patient experience on povetacicept administered via autoinjector - Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) today announced the publication of Phase 3 RAINIER results for povetacicept in the New England Journal of Medicine (NEJM), presentation of these data at the American Soc
BeOne Medicines Reports Sustained Survival Benefit with TEVIMBRA-ZIIHERA Combination in First-Line HER2+ Gastroesophageal Cancer23.10.2026 16:15:00 CEST | Press release
New data from HERIZON-GEA-01 Phase 3 trial show 36-month overall survival of nearly 40% with TEVIMBRA plus ZIIHERA and chemotherapy, and median OS reaching 27 monthsTEVIMBRA-containing arm was associated with a four-month longer median OS compared with ZIIHERA plus chemotherapy BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new survival results from the planned second interim analysis (IA2) and final formal analysis of the Phase 3 HERIZON-GEA-01 trial, further confirming the benefit of TEVIMBRA® (tislelizumab) plus ZIIHERA® (zanidatamab) and chemotherapy as first-line treatment for patients with HER2-positive locally advanced or metastatic gastroesophageal adenocarcinoma (GEA). The results will be presented today as a late-breaking abstract during a rapid oral session at the European Society for Medical Oncology (ESMO) Congress 2026 in Madrid, Spain (LBA79). Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne,
Lifezone Metals Confirms Advanced Negotiations with Orion CMC on Kabanga Nickel Project23.10.2026 16:10:00 CEST | Press release
Lifezone Metals Limited (NYSE: LZM) notes comments made today by Oskar Lewnowski, Founder and Group Chief Executive of Orion Resource Partners, in an interview with Bloomberg Television regarding the Company’s Kabanga Nickel Project in Tanzania. In response to inbound inquiries from media outlets and investors following the interview, the Company can confirm that negotiations with Orion Critical Mineral Consortium (Orion CMC) regarding a significant equity investment into the Kabanga Nickel Project are at an advanced stage. The Orion CMC is a global investment platform launched by Orion Resource Partners in partnership with the U.S. International Development Finance Corporation (DFC) and Abu Dhabi's sovereign investor ADQ. As previously announced, the Company has been running a competitive process, led by Standard Chartered Bank, to secure a strategic investment into the Kabanga Nickel Project. Social Media LinkedIn | X | YouTube About Lifezone Metals Lifezone Metals (NYSE: LZM) is com
inDrive and Pony.ai Announce Collaboration to Explore Autonomous Mobility in Kazakhstan Built on NVIDIA Hyperion23.10.2026 15:00:00 CEST | Press release
Collaboration will establish the roadmap for bringing Pony.ai robotaxis to Kazakhstan on the inDrive ride-hailing platform, leveraging the NVIDIA Hyperion and the NVIDIA Halos safety system. inDrive, the global mobility and delivery platform, today announced it has signed a memorandum of understanding (MOU) with NVIDIA and Pony.ai, a global leader in the large-scale commercialization of autonomous driving technology, to explore the future of autonomous ride-hailing. Kazakhstan will serve as the first test market. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261023143469/en/ inDrive partners with Pony.ai and NVIDIA to explore autonomous mobility in Kazakhstan Kazakhstan was chosen first for its regulatory readiness following the creation of the country’s first structured legal framework for driverless transport, as part of its “Year of Digitalization and Artificial Intelligence.” Combined with Kazakhstan’s position as a lea
Brenus Pharma's Novel In Vivo Immunotherapy STC-1010 Shows Safety, Activating T Cells in First-Line MSS Metastatic Colorectal Cancers With 2 Complete Responses.23.10.2026 14:50:00 CEST | Press release
Phase Ia BreAK CRC-001 at ESMO 2026: 43% of patients, all initially unresectable, became eligible for surgery Poster 1023P – Developmental Therapeutics Brenus Pharma, a clinical-stage biotech company, announced first data from the Phase Ia dose escalation of BreAK CRC-001. Nine unresectable patients were treated; 89% had liver metastases and 89% KRAS-mutant tumors, a population refractory to immunotherapy. Median follow-up: 8 months (1–14; data cut-off 6/08/2026). 95% of metastatic colorectal cancers are pMMR/MSS tumors, poorly immunogenic and resistant to immunotherapy. STC-1010, the company’s lead in vivo DC-engager, is designed to make these “cold” tumors visible to immune cells. Safety: no dose-limiting toxicity, only grade 1–2 related adverse events. Clinical activity (seven evaluable patients, RECIST 1.1): 100% disease control, 57% objective response rate (4/7). 43% of patients became operable (3/7): two with no evidence of disease afterward. Molecular profile: ctDNA dropped by u
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom